Shire Overstates Benefits of Attention Deficit Drug Intuniv, US FDA Says – Bloomberg
Shire Overstates Benefits of Attention Deficit Drug Intuniv, US FDA Says Bloomberg The Dublin-based company has been betting on Intuniv and Vyvanse, the successor to Shire's Adderall treatment for hyperactivity, to counter losses after ... and more » |